Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer

Figure 3

Independent validation of the prognostic value of the signature. A: The validation strategy used for the construction of prediction models and the evaluation of predicted outcomes based on gene expression signature. B: Kaplan-Meier plots of progression of NMIBC patients from an independent European cohort predicted by compound covariate predictor (CCP), Bayesian compound covariate predictor (BCC), linear discriminator analysis (LDA), nearest centroid classification (NC), and support vector machines (SVM).

Back to article page
\